Intellia Therapeutics was formed in 2014 to lead the industry in one of the most promising new areas of therapeutic development: gene editing and repair using CRISPR-Cas9 technology. Intellia holds exclusive access to one of the most comprehensive intellectual property platforms available for the therapeutic use of CRISPR-Cas9. The company is advancing a broad pipeline toward clinical development, including ex vivo and in vivo approaches. Intellia closed a Series A round in 2014 led by Atlas Venture and Novartis.The average employee at Intellia Therapeutics makes $79,975 per year. Pay at Intellia Therapeutics is significantly lower than some of its highest paying competitors, like Gilead Sciences, bluebird bio, and Vertex Pharmaceuticals, which pay $99,828, $98,505, and $95,952, respectively.Based in Cambridge, MA, Intellia Therapeutics is a small health care company with only 211 employees and an annual revenue of $57.9M.
Intellia Therapeutics's mission statement
To support the manufacturing of key components for its CRISPR-based investigational therapies.
In demand companies are hiring! Let Zippia apply for you!
-
Intellia Therapeutics employee reviews
Be the first to review!
Do you work at Intellia Therapeutics?
Help job seekers learn about working at Intellia Therapeutics
The founders of Intellia Therapeutics are Jean-Francois B. Formela, Fred Ehrenkranz Cohen, Muna Bhanji, Derrick Rossi, Jennifer Doudna, Nessan Bermingham, Rodolphe Barrangou, Andy May, Erik Sontheimer and Luciano Marraffini.
The key people at Intellia Therapeutics are Jean-Francois B. Formela, Fred Ehrenkranz Cohen and Muna Bhanji.
Key people
Jean-Francois B. Formela
Fred Ehrenkranz Cohen
Muna Bhanji
Derrick Rossi
Jennifer Doudna
Nessan Bermingham
Rodolphe Barrangou
Andy May
Erik Sontheimer
Luciano Marraffini
Intellia Therapeutics rankings
Intellia Therapeutics is ranked #93 on the Best Health Care companies to work for in Massachusetts list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.
Rate Intellia Therapeutics' promotion and raise policies.
Do you work at Intellia Therapeutics?
Did Intellia Therapeutics' compensation package meet your expectations?
Intellia Therapeutics financial performance
9.2
Performance score
We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.
Intellia Therapeutics currently has 52.1M in revenue. Intellia Therapeutics's most recent quarter produced 13.6m (q2'2023).
Intellia Therapeutics annual revenue
$58M
$46M
$35M
$23M
$12M
$0
2019
2020
2021
2022
2023
2024
Highest paying Intellia Therapeutics competitors
Compare Intellia Therapeutics salaries to competitors, including Gilead Sciences, bluebird bio, and Vertex Pharmaceuticals. Employees at Gilead Sciences earn the highest average yearly salary of $99,828. The salaries at bluebird bio average $98,505 per year, and the salaries at Vertex Pharmaceuticals come in at $95,952 per year.
Rank
Company
Average salary
Jobs
1
$99,828
0
2
$98,505
0
3
$95,952
0
4
$90,328
0
5
$87,092
0
6
$85,589
0
7
$85,008
0
8
$84,495
0
9
$83,561
0
10
$83,416
0
Show more
Are you an executive, HR leader, or brand manager at Intellia Therapeutics?
Claiming and updating your company profile on Zippia is free and easy.
Intellia Therapeutics FAQs
When was Intellia Therapeutics founded?
How many employees does Intellia Therapeutics have?
Zippia gives an in-depth look into the details of Intellia Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Intellia Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Intellia Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Intellia Therapeutics. The data presented on this page does not represent the view of Intellia Therapeutics and its employees or that of Zippia.
Intellia Therapeutics may also be known as or be related to INTELLIA THERAPEUTICS INC., Intellia Therapeutics, Intellia Therapeutics Inc and Intellia Therapeutics, Inc.